Article
Adam Feinberg, associate professor of Biomedical Engineering at Carnegie Mellon University, sat down with BioPharm International to discuss challenges in 3D bioprinting.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.